Assessment of the genotoxic potential of ISIS 2302: A phosphorothioate oligodeoxynucleotide

Mutagenesis

Volumn 17, Issue 3, 2002, Pages 201-209

  Henry, Scott P ^a   Monteith, D K ^b   Matson, J E ^a   Mathison, B H ^a   Loveday, K S ^a,c   Winegar, R A ^a,d   Lee, P S ^a,e   Riccio, E S ^a,e   Bakke, J P ^a,e   Levin, A A ^a  

^a ISIS PHARMACEUTICALS   (United States)

^b Sierra Biomedical   (United States)

^c Shire Canada   (Canada)

^d MIDWEST RESEARCH INSTITUTE   (United States)

^e SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE; DNA; IMMUNOSUPPRESSIVE AGENT; NUCLEOTIDE; OLIGONUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; BONE MARROW; CHO CELL; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; GEL ELECTROPHORESIS; GENE MUTATION; GENOTOXICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAMMAL CELL; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; TARGET CELL; ANIMAL; CAPILLARY ELECTROPHORESIS; CHEMICAL MODEL; CHROMOSOME; DOSE RESPONSE; DRUG EFFECT; HAMSTER; METABOLISM; MUTATION; TIME;

ANIMALIA; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; NEGIBACTERIA; SALMONELLA TYPHIMURIUM;

ANIMALS; BONE MARROW; CHO CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES; CRICETINAE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, CAPILLARY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MODELS, CHEMICAL; MUTATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDES; RNA, MESSENGER; SALMONELLA TYPHIMURIUM; THIONUCLEOTIDES; TIME FACTORS;

EID: 0036001249     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/17.3.201     Document Type: Article

References (40)

1. Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice
2. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test
3. The genotoxic potential of bases and nucleosides
4. Antisense oligonucleotides in inflammation research
5. Inhibition of cell adhesion molecule expression with antisense oligonucleotides: Activity in-vitro and in-vivo
6. Mutagenicity of thymidine to cultured Chinese hamster cells
7. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues
8. Histological localization of phosphorothioate oligodeoxynucleotides in normal rodent tissue
9. Specific gene mutations in L5178Y cells in culture
10. Guide for performing the mouse lymphoma assay for mammalian cell mutagenicity
11. Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon
12. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats
13. 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats
14. Therapeutic applications of oligonucleotides
15. Progress in antisense therapeutics
16. Cytological methods for detecting chemical mutagens
17. Hybridization considerations affecting antisense drugs
18. Report from working group on in vitro tests for chromosomal aberrations
19. Recommendations for the performance of bacterial mutation assays
20. Pharmacokinetics and Metabolism in Mice of a Phospherothirate Oligonucleotide Antisense Inhibitor of C-RAF-1 Kinase Expression
21. Phase I safety and pharmacokinetic profile of an ICAM-1 antisense oligodeoxynucleotide (ISIS 2302)
22. In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration
23. An application of Acridine Orange fluorescent staining to the micronucleus test
24. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection
25. A mechanism for gene conversion in fungi
26. Tables for determining the statistical significance of mutation frequencies
27. International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: A critical factor in the maintenance of genetic stability
28. Quantitation of phosphorothioate oligonucleotides in human plasma
29. Relative thermodynamic stability of DNA, RNA and DNA:RNA hybrid duplexes: Relationship with base composition and structure
30. Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes
31. Statistical analyses for in vitro cytogenetic assays using Chinese hamster ovary cell
32. Revised methods for the Salmonella mutagenicity test
33. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood
34. A general model for genetic recombination
35. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities
36. Uptake characteristics of oligonucleotides in the isolated rat liver perfusion system
37. Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells
38. Gene inhibition using antisense oligodeoxynucleotides
39. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes
40. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of steroid-dependent Crohn's disease